Androgen replacement in young hypogonadal men: a 2 year randomized, double-blind placebo controlled study [Testosteron substitutionsbehandling till unga hypogonadala män: 2 års randomiserad, dubbel-blind, placebo kontrollerad studie].

Trial Profile

Androgen replacement in young hypogonadal men: a 2 year randomized, double-blind placebo controlled study [Testosteron substitutionsbehandling till unga hypogonadala män: 2 års randomiserad, dubbel-blind, placebo kontrollerad studie].

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2013

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Therapeutic Use
  • Acronyms ARYHM-1
  • Most Recent Events

    • 13 Oct 2012 Planned End Date changed from 21 Dec 2014 to 1 Jan 2015 as reported by European Clinical Trials Database.
    • 04 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top